CClinicalTrials.gg
CompletedNCT04214054Updated Aug 20, 2020

Maxillary Sinus Lift With and Without Self-hardening Biphasic Calcium Phosphate.

An interventional study of Moldable self-hardening biphasic calcium phosphate graft and No graft material placed - Blood Clot only in Maxillary Sinus Augmentation, sponsored by Nourhan M.Aly. Completed at 1 site in Egypt. Open to participants aged 30 Years to 50 Years. Per ClinicalTrials.gov, last updated 2020-08-20.

Sponsored by Nourhan M.Aly · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 7 months after the study started (first participant enrolled May 2018, registered Dec 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
30 Years to 50 Years
Sex
All
01

Study summary

This study was carried out to compare the outcome of sinus lift without grafting material, versus the use of moldable, self hardening calcium phosphate biomaterials with simultaneous implant placement.

Read the detailed description

This study was designed as a randomized controlled clinical trial, the study population consisted of 20 patients with missing maxillary posterior teeth and residual bone height 5-7mm. The sample was selected conveniently according to a list of inclusion and exclusion criteria, the participants were allocated randomly into two equal groups. All patients had sinus lift using piezosurgery device with simultaneous implant placement. In group I, blood clot was the only filling material. In group II, moldable, self-hardening calcium phosphate was the filling material. Clinical and radiographic evaluations were done through 6 months postoperatively.

02

Conditions studied

  • Maxillary Sinus Augmentation

Keywords

  • maxillary sinus lift
  • Piezosurgery
  • Grafting materials
03

In context

Lead sponsor

Nourhan M.Aly is the lead sponsor of 48 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients having missing posterior maxillary teeth
  • The vertical height between the floor of the maxillary sinus and the alveolar crest ranged between 5 and 7mm,
  • Free from maxillary sinus pathologies
  • Adequate oral hygiene
  • Acceptable interarch space for the prosthesis

Exclusion criteria

Exclusion Criteria:

  • Patients with systemic diseases that directly affect the surgical procedure and/ or the healing of the bone
  • immunocompromised status
  • Alcoholism
  • psychiatric disorders
  • Parafunctional habits
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Moldable self-hardening biphasic calcium phosphate graft

    Easy graft, a moldable osteocondutive allograft formed of 60% hydroxylapatite and 40% β-tricalcium phosphate (Easy-graft, Sunstar, Gruidor, Degradable solutions AG, Swizerlard).

    Other: Moldable self-hardening biphasic calcium phosphate graft

  • Placebo comparator
    No graft material

    Procedure: No graft material placed - Blood Clot only

Interventions

  • OtherMoldable self-hardening biphasic calcium phosphate graft

    Incision was performed in the canine area then a full thickness mucoperiosteal flap was elevated and exposure of the lateral aspect of the maxillary sinus. Osteotomy of the buccal window was performed using the piezosurgery device followed by meticulous dissection of the sinus membrane. Drilling the site were implants were to be placed, guided by the preformed surgical stent. Implants of appropriate size were torqued to engage the apical aspect of the implant recipient site. The sinus was augmented with moldable self-hardening biphasic calcium phosphate. Repositioning and suturing of the flap using 3-0 black silk suture material.

  • ProcedureNo graft material placed - Blood Clot only

    A pyramidal full thickness mucoperiosteal flap was performed distal to the canine area with a crestal incision located palatally in the edentulous area and vertical extension of the incision to the buccal vestibule using Bard Parker blade number 15. The flap was reflected exposing the alveolar bone. Lateral window was performed and the sinus membrane was elevated using piezo surgery. Drilling at the sites where implants were to be placed was done using Neobiotech implant drilling Kit. Implants. Implants were placed in a self-tapping fashion using a torque wrench. Flaps were replaced back and sutured using 3-0 black silk suture material.

06

What researchers measure

Primary outcomes

  1. Pain Evaluation

    Pain was assessed through on a 10-point Visual Analogue Scale (VAS). (0-1= None, 2-4= Mild, 5-7= Moderate, 8-10= Severe)

    Time frame: 1 week

  2. Wound healing

    The presence of alveolar osteitis (dry socket) will be determined clinically using BLUM'S criteria. Wound healing was assessed and recorded depending on the absence or presence of dehiscence, every opening along the incision will be recorded as dehiscence , dental tweezers will be used to identify it.

    Time frame: 1 week

  3. Radiographic Evaluation

    Cone beam computed tomography (CBCT) was done. The apparatus and the settings were kept the same during all the preoperative scans to evaluate the amount of vertical bone height gained, the change of bone density and the marginal bone loss postoperatively.

    Time frame: 6 months

  4. Implant stability

    Examining implant stability was done using Osstell (Osstell co. Swedan). It is a noninvasive and easy-to-use system to determine implant stability and to assess the process of osseointegration.

    Time frame: 6 months

07

Study locations

1 site
  • Faculty of Dentistry, Alexandria University
    Alexandria, 21512, Egypt
08

References and documents

Publications

  • Mazor Z, Horowitz RA, Del Corso M, Prasad HS, Rohrer MD, Dohan Ehrenfest DM. Sinus floor augmentation with simultaneous implant placement using Choukroun's platelet-rich fibrin as the sole grafting material: a radiologic and histologic study at 6 months. J Periodontol. 2009 Dec;80(12):2056-64. doi: 10.1902/jop.2009.090252. PubMed 19961389 ↗
  • Del Fabbro M, Testori T, Francetti L, Weinstein R. Systematic review of survival rates for implants placed in the grafted maxillary sinus. Int J Periodontics Restorative Dent. 2004 Dec;24(6):565-77. PubMed 15626319 ↗
  • Cha HS, Kim A, Nowzari H, Chang HS, Ahn KM. Simultaneous sinus lift and implant installation: prospective study of consecutive two hundred seventeen sinus lift and four hundred sixty-two implants. Clin Implant Dent Relat Res. 2014 Jun;16(3):337-47. doi: 10.1111/cid.12012. Epub 2012 Nov 15. PubMed 23157674 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 20, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04214054
Lead sponsor
Nourhan M.Aly
Collaborators
Alexandria University
Responsible party
Nourhan M.Aly (Instructor of Dental Public Health, University of Alexandria) — Sponsor-investigator
First posted
Dec 30, 2019
Start date
May 13, 2018
Primary completion
Apr 20, 2019
Completion
Sep 25, 2019
Last update
Aug 20, 2020

Study contacts

Shaimaa A. El Sadek, M.Sc
principal investigator · Faculty of Dentistry, Alexandria University, Egypt
Ahmed A. A. Sharara, PhD
study chair · Faculty of Dentistry, Alexandria University, Egypt
Magda M Saleh, PhD
study chair · Faculty of Dentistry, Alexandria University, Egypt
Nevien Shawky, PhD
study chair · Faculty of Dentistry, Alexandria University, Egypt

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion